Syneos Health appointed Michael Bonello as CFO, effective July 1. Stanford Rudnick will continue to serve as Interim CFO until that time. Bonello most recently served as Chief Financial Officer of Clario, a clinical trial data collection company, since 2021. From 2008 to 2021, Bonello held roles of increasing responsibility at Nasdaq-listed PRA Health Sciences, including Executive Vice President and Chief Financial Officer from 2018 through the company’s sale to ICON plc, and previously as Senior Vice President, Accounting and Corporate Controller from 2008 to 2018. Earlier in his career, he held financial leadership roles at Cree, Inc. and Genworth Financial, and was a senior manager in the audit practice at PricewaterhouseCoopers LLP.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on SYNH:
- Syneos Health Appoints Michael Bonello as Chief Financial Officer
- Syneos Health Schedules First Quarter 2023 Earnings Call for Wednesday, May 10th, 2023
- Syneos Spikes as Private Equity Considers Getting In
- Syneos Health attracting interest from multiple PE firms, Dealreporter says
- Syneos Health Wins 2023 ViE Award